Wellorithm vs TMates: 50-State Access or Flat $199/month

Comparing Wellorithm vs TMates quickly: Wellorithm emphasizes nationwide clinician coverage plus compounded semaglutide and tirzepatide with entry pricing starting at $147, while TMates offers a flat $199/month semaglutide program with 24/7 U.S. doctor access. Early verdict: choose Wellorithm if you need wider drug options and state coverage; choose TMates if you prefer a predictable flat monthly price and continuous physician availability.

Start Wellorithm quiz from $147

Direct comparison: core differences between Wellorithm vs TMates

This comparison focuses on the most distinctive differences supplied in the source material: drug selection and formulation, pricing model and transparency, clinician availability and support, medication sourcing and compounding notes, and state coverage.

1. Drug selection and formulation

Wellorithm offers both compounded semaglutide and compounded tirzepatide, including injections and oral dissolving tablets, according to the source. TMates highlights clinically dosed compounded semaglutide and has limited public detail on tirzepatide availability. Both providers use compounded medications; the regulatory note supplied states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

2. Pricing model and transparency

Wellorithm advertises options “starting at $147” and multiple price points appear in landing copy, but the source states Wellorithm does not publish full pricing online and you receive a personalized quote after the intake quiz. TMates is explicit about price: the source lists a flat $199/month rate “at every dose” with no step-up fees, and multiple package prices are shown for different term lengths. If transparent, fixed monthly pricing matters, TMates provides clearer upfront cost information; Wellorithm requires the intake to see your specific cost.

See TMates pricing at $199/month

3. Clinician availability and support

Both platforms report licensed clinicians covering all 50 states. Wellorithm notes licensed clinicians in all 50 states and a fully virtual consultation model with medication shipped to your home. TMates also notes licensed coverage in all 50 states but emphasizes 24/7 access to U.S.-based doctors and virtual check-ins. The source frames TMates as offering continuous physician availability rather than messaging-only support.

4. Medication sourcing and domestic formulation

TMates states medications are formulated in U.S.-based facilities and describes clinically dosed compounded semaglutide. Wellorithm provides compounded semaglutide and tirzepatide dispensed after clinician review; the source repeatedly warns that compounded medications are not FDA-approved. TMates highlights domestic formulation as a quality point; Wellorithm highlights access to both main GLP-1 compounds.

5. Best-fit patient profiles

According to the source, Wellorithm is best for patients in states with limited GLP-1 telehealth options who need both semaglutide and tirzepatide access and prefer a fully virtual workflow. TMates is presented as best for patients who want a straightforward, flat-rate, clinician-supervised semaglutide program with 24/7 U.S. doctor access.

How the platforms handle medical oversight and titration

Both platforms use virtual clinician review to determine medical appropriateness. Wellorithm describes a 2-minute online quiz, clinician review, and ongoing virtual check-ins to keep titration on track. TMates offers virtual check-in appointments and emphasizes physician availability between check-ins for guidance. If ongoing access to an on-call physician is important, TMates highlights 24/7 U.S. doctor access as a distinguishing feature.

Take the Wellorithm eligibility quiz

Regulatory note and nothing assumed

Both providers offer compounded medications. The source explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The sources do not supply independent guarantees about medical outcomes or specifics about branded products; do not assume insurance, efficacy, or shipment timing beyond what each landing copy states.

Begin Wellorithm intake for a quote

Bottom line and choosing between Wellorithm vs TMates

Wellorithm vs TMates boils down to access and options versus price clarity and 24/7 physician access. Wellorithm offers broader drug selection with both compounded semaglutide and tirzepatide and licensed clinicians in all 50 states, but pricing is provided after the intake quiz. TMates provides a transparent flat $199/month pricing model, clinically dosed compounded semaglutide formulated in U.S. facilities, and 24/7 U.S. doctor access.

Choose Wellorithm if you need access to both compounded semaglutide and compounded tirzepatide and value licensed clinicians in all 50 states. Choose TMates if you want a predictable flat $199/month rate at every dose and continuous U.S.-based physician availability.